Compare
5 stocks, side by sideRelative performance · rebased to 100
IMTXCOAGAVLNJBIOSVRA
| IMTXImmatics N.V. | COAGHemab Therapeutics Holdings, Inc. | AVLNAvalyn Pharma Inc. | JBIOJade Biosciences, Inc. | SVRASavara Inc. | |
|---|---|---|---|---|---|
| Smart Score | 2/10 | - | - | 3/10 | 3/10 |
| Price | $9.42 | $44.68 | $37.73 | $19.44 | $5.53 |
| 1 month | 0.00% | -14% | +16% | -13% | -4.8% |
| 1 year | +52% | - | - | +159% | +81% |
| 5 year | -21% | - | - | -96% | +350% |
| P/E (TTM) | -13.1 | - | - | 2.3 | -9.9 |
| P/E vs sector | - | - | - | -92% | - |
| Market cap | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.